M. Blute

Journal of Urology · 2000–2015

A researcher in the Science corpus: 12 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Who trusts M. Blute overall

1. Pedro C. Barata
2. B. Rini
3. Patrick Royston

Papers from M. Blute's perspective

Ordered by how strongly the researchers M. Blute trusts endorse each paper. Same corpus, a different order for every researcher.

1. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
2. Modeling Survival Data: Extending the Cox Model
3. The changing natural history of renal cell carcinoma. (Journal of Urology)
4. A postoperative prognostic nomogram for renal cell carcinoma. (Journal of Urology)
5. AJCC Cancer Staging Manual. 6th ed
6. Improved prognostication of renal cell carcinoma using an integrated staging system. (Journal of Clinical Oncology)
7. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
8. Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1 (Journal of Immunology)
9. B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression (Clinical Cancer Research)
10. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. (Proceedings of the National Academy of Sciences of the United States of America)

Their papers

• Comprehensive Molecular Characterization of Papillary Renal Cell Carcinoma (2015) — 1,150 citations
• Every minute counts when the renal hilum is clamped during partial nephrectomy. (2010) — 747 citations
• Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (2008) — 701 citations
• Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. (2006) — 866 citations
• The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus (2004) — 607 citations
• Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. (2004) — 620 citations
• Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. (2004) — 597 citations
• Solid renal tumors: an analysis of pathological features related to tumor size. (2003) — 1,090 citations
• Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma (2003) — 1,089 citations
• Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma (2003) — 818 citations
• An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. (2002) — 1,154 citations
• Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. (2000) — 674 citations